The efficacy of Ado-trastuzumab emtansine in HER-2 aberrant non-small cell lung cancer

被引：0
|
作者：
Xia, Yang [1 ]
Huang, Xiu [1 ]
Jin, Rui [1 ]
Li, Wen [1 ]
Shen, Huahao [1 ]
机构：
[1] Zhejiang Univ, Hangzhou, Peoples R China
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
D O I：
10.1183/13993003.congress-2019.PA4669
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA4669
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Aberrant methylation in non-small cell lung cancer
    Makoto Suzuki
    Ichiro Yoshino
    Surgery Today, 2010, 40 : 602 - 607
  • [42] Endothelin causes transactivation of the EGFR and Her-2/Neu in non-small cell lung cancer cells
    Moody, Terry W.
    Alvarez, Irene Ramos
    Mantey, Samuel
    Jensen, Robert T.
    CANCER RESEARCH, 2016, 76
  • [43] Aberrant methylation in non-small cell lung cancer
    Suzuki, Makoto
    Yoshino, Ichiro
    SURGERY TODAY, 2010, 40 (07) : 602 - 607
  • [44] Ado-trastuzumab emtansine for the treatment of human epidermal growth factor receptor 2 positive metastatic breast cancer
    Patel, Kiki
    Hageman, Kelly
    Cooper, Maryann
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (07) : 537 - 548
  • [45] Trastuzumab deruxtecan shows durable activity in HER2-mutant non-small cell lung cancer
    O'Rourke, Kate
    CANCER, 2022, 128 (05) : 938 - 938
  • [46] Safety, efficacy and survival outcome of Ado-trastuzumab emtansine (T-DM1) in patients with metastatic HER2-positive breast cancer: An Indian experience.
    Gogia, Ajay
    Gupta, Anshul
    Deo, S. V. S.
    Sharma, Dayanand
    Mathur, Sandeep
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [47] Ado-trastuzumab emtansine (T-DM1) is effective against established HER2-positive breast cancer brain metastases in mice
    Askoxylakis, V.
    Ferraro, G.
    Kodack, D.
    Badeaux, M.
    Jain, R.
    CANCER RESEARCH, 2016, 76
  • [48] Trastuzumab emtansine suppresses the growth of HER2-positive small-cell lung cancer in preclinical models
    Morimura, Osamu
    Minami, Toshiyuki
    Kijima, Takashi
    Koyama, Shohei
    Otsuka, Tomoyuki
    Kinehara, Yuhei
    Osa, Akio
    Higashiguchi, Masayoshi
    Miyake, Kotaro
    Nagatomo, Izumi
    Hirata, Haruhiko
    Iwahori, Kota
    Takimoto, Takayuki
    Takeda, Yoshito
    Kida, Hiroshi
    Kumanogoh, Atsushi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 488 (04) : 596 - 602
  • [49] Effect of early adverse events resulting in ado-trastuzumab emtansine dose adjustments on survival outcomes of HER2+advanced breast cancer patients
    Tang, Ethan
    Rowland, Andrew
    McKinnon, Ross A.
    Sorich, Michael J.
    Hopkins, Ashley M.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 178 (02) : 473 - 477
  • [50] HER-2/neu detection by immunohistochemistry in non-small cell carcinomas of the lung.
    Barcus, ME
    Lamb, TD
    Workman, RH
    Grimes, MM
    Kornstein, MJ
    Berezowski, K
    LABORATORY INVESTIGATION, 1999, 79 (01) : 181A - 181A
12345